Intersect ENT, Inc. Foreign Currency Transaction Gain (Loss), Unrealized
Intersect ENT, Inc. reported Foreign Currency Transaction Gain (Loss), Unrealized of $583.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2022-05-04
- Intersect ENT, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2022-03-31 was $583.00K, a 70.45% decline year-over-year.
- Intersect ENT, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2021-12-31 was $279.00K.
- Intersect ENT, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2021-09-30 was $794.00K.
- Intersect ENT, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2021-06-30 was -$548.00K.
- Intersect ENT, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2021 was $2.50M.
- Intersect ENT, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2020 was -$2.23M.
- Intersect ENT, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2019 was $0.00.
- Intersect ENT, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2018 was $0.00.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|
| 2022-03-31 | $583.00K 10-Q · filed 2022-05-04 | $862.00K derived: sum of 2 quarters · filed 2022-05-04 | $1.66M derived: sum of 3 quarters · filed 2022-05-04 | $1.11M derived: sum of 4 quarters · filed 2022-05-04 |
| 2021-12-31 | $279.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $1.07M derived: sum of 2 quarters · filed 2022-03-08 | $525.00K derived: sum of 3 quarters · filed 2022-03-08 | $2.50M 10-K · filed 2022-03-08 |
| 2021-09-30 | $794.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $246.00K derived: sum of 2 quarters · filed 2021-11-02 | $2.22M 10-Q · filed 2021-11-02 | -$14.00K derived: sum of 4 quarters · filed 2022-05-04 |
| 2021-06-30 | -$548.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $1.43M 10-Q · filed 2021-08-06 | -$808.00K derived: sum of 3 quarters · filed 2022-05-04 | -$808.00K derived: sum of 4 quarters · filed 2022-05-04 |
| 2021-03-31 | $1.97M 10-Q · filed 2022-05-04 | -$260.00K derived: sum of 2 quarters · filed 2022-05-04 | -$260.00K derived: sum of 3 quarters · filed 2022-05-04 | -$260.00K derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | -$2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$2.23M derived: sum of 2 quarters · filed 2022-03-08 | -$2.23M derived: sum of 3 quarters · filed 2022-03-08 | -$2.23M 10-K · filed 2022-03-08 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-08 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-09 |